Interferon Regulatory Factor 3-dependent Responses to Lipopolysaccharide Are Selectively Blunted in Cord Blood Cells
Overview
Authors
Affiliations
The synthesis of interferon-beta (IFNbeta) and IFN-inducible factors elicited by lipopolysaccharide (LPS) depends on the transcriptional activity of interferon regulatory factor 3 (IRF-3) downstream of Toll-like receptor-4 (TLR4). To examine the ability of human newborns to mount TLR4-mediated IRF-3-dependent responses, we analyzed the pattern of genes expressed on the addition of LPS to cord blood or cord blood monocyte-derived dendritic cells (moDCs). Expression of IFNbeta and IFN-inducible genes was selectively impaired in neonatal blood and moDCs as compared with their adult counterparts. This selective defect was confirmed by microarray experiments on moDCs. Altered expression of IFN-inducible genes was related to impaired IFNbeta synthesis because IFNbeta signaling was functional in neonatal moDCs. However, addition of exogenous IFNbeta failed to restore LPS-induced IL-12p70 synthesis which was previously shown to be defective in neonatal moDCs. Although LPS-induced IRF-3 nuclear translocation was observed both in adult and neonatal moDCs, IRF-3 DNA-binding activity and association with the coactivator CREB-binding protein (CBP) were decreased in neonatal as compared with adult moDCs. We conclude that impaired IRF-3/CBP interaction in neonatal blood cells exposed to LPS is associated with impaired expression of IFNbeta and IFN-inducible genes. Because IRF-3 activity is also required for IL-12p70 synthesis, our findings provide a molecular basis for the decreased ability of LPS-stimulated neonatal moDCs to elicit Th1-type responses.
Mai K, Pan W, Lin Z, Wang Y, Yang Z Adv Biotechnol (Singap). 2025; 3(1):5.
PMID: 39883362 DOI: 10.1007/s44307-025-00057-9.
Eddens T, Parks O, Zhang Y, Manni M, Casanova J, Ogishi M Mucosal Immunol. 2024; 17(3):476-490.
PMID: 38176655 PMC: 11180597. DOI: 10.1016/j.mucimm.2023.12.004.
Dysregulated monocyte-derived macrophage response to Group B in newborns.
Ravi D, Ntinopoulou E, Guetta N, Weier M, Vogel V, Spellerberg B Front Immunol. 2023; 14:1268804.
PMID: 38035076 PMC: 10682703. DOI: 10.3389/fimmu.2023.1268804.
Interferons-Implications in the Immune Response to Respiratory Viruses.
Bergeron H, Hansen M, Tripp R Microorganisms. 2023; 11(9).
PMID: 37764023 PMC: 10535750. DOI: 10.3390/microorganisms11092179.
Neonatal Immune Responses to Respiratory Viruses.
Eddens T, Parks O, Williams J Front Immunol. 2022; 13:863149.
PMID: 35493465 PMC: 9047724. DOI: 10.3389/fimmu.2022.863149.